🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Alzheimer disease 3

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) NCT06947941Phase 322 sites📍 Gilbert📍 Chino📍 Naples Bristol-Myers Squibb · Tests: KarXT, KarX-EC, KarXT + KarX-EC Arm Matching Placebo A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2) NCT06976203Phase 3128 sites📍 Fullerton📍 Irvine📍 Los Angeles Bristol-Myers Squibb · Tests: KarXT, KarX-EC, Placebo A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease NCT06996730Phase 2, Phase 31 site📍 Medellín Banner Health · Tests: Donanemab, RG6289, Donanemab placebo, RG6289 placebo A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK NCT06372821Phase 12 sites📍 St Louis📍 London University College, London · Tests: NIO752, Placebo A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease NCT06976216Phase 3119 sites📍 Long Beach📍 Redlands📍 Basalt Bristol-Myers Squibb · Tests: KarXT, KarX-EC, Placebo Adapting RDAD for DS NCT07425769NA1 site📍 Kansas City University of Kansas Medical Center · Tests: Remote Exercise Sessions, Caregiver Education Sessions A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) NCT06585787Phase 3296 sites📍 Chandler📍 Gilbert📍 Phoenix Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Tests: KarXT, Placebo Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney) NCT06534723Phase 31 site📍 Fuzhou Sichuan Jishengtang Pharmaceutical Co., Ltd. · Tests: Wujia Yizhi granules, Placebo A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) NCT06937229Phase 3252 sites📍 Chandler📍 Scottsdale📍 Anaheim Bristol-Myers Squibb · Tests: KarXT, KarX-EC A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease NCT06702124Phase 31 site📍 Rome I.R.C.C.S. Fondazione Santa Lucia · Tests: Rotigotine 4Mg/24Hrs Patch, Placebo Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease NCT06808984Phase 277 sites📍 Homewood📍 Huntsville📍 Phoenix Celgene · Tests: BMS-986368, Placebo A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease NCT07011745Phase 3143 sites📍 Chandler📍 Chandler📍 Chandler Bristol-Myers Squibb · Tests: Xanomeline/Trospium Chloride Capsule, Xanomeline Enteric Capsule, Placebo A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) NCT07011732Phase 3162 sites📍 Scottsdale📍 Anaheim📍 Fresno Bristol-Myers Squibb · Tests: Xanomeline/Trospium Chloride Capsule, Xanomeline Enteric Capsule, Placebo Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia NCT07284472Phase 2, Phase 349 sites📍 Murrieta📍 Indianapolis📍 Flowood Exciva GmbH · Tests: EXV-802, Placebo, EXV-801 A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). NCT07602582Phase 359 sites📍 Phoenix📍 Huntington Beach📍 Irvine Eli Lilly and Company · Tests: Donanemab, Placebo A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) NCT05511363Phase 3129 sites📍 Homewood📍 Phoenix📍 Encino Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Tests: KarXT, Placebo Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant NCT06563895Phase 3104 sites📍 La Jolla📍 Los Angeles📍 San Francisco Eidos Therapeutics, a BridgeBio company · Tests: Acoramidis, Placebo oral tablet Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER) NCT07435467n/a3 sites📍 Ancona📍 Fermo📍 Messina Istituto Nazionale di Ricovero e Cura per Anziani · Tests: collection of blood samples Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease NCT07062198Phase 38 sites📍 Alanya📍 Erzurum📍 Istanbul ScandiBio Therapeutics AB · Tests: Combined metabolic activators, Collagen and maltodextrin Communication Bridge 3 Study NCT06191198Phase 21 site📍 Chicago University of Chicago · Tests: Communication Bridge™, Evidence-Based Impairment Focused [18F]PI-2620 Phase 3 Histopathological Study NCT05641688Phase 325 sites📍 Phoenix📍 Sun City📍 Los Angeles Lantheus Biosciences Ltd. · Tests: [18F]PI-2620 Dominantly Inherited Alzheimer Network (DIAN) NCT00869817n/a26 sites📍 Jacksonville📍 Indianapolis📍 Boston Washington University School of Medicine A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) NCT06126224Phase 3157 sites📍 Chandler📍 Phoenix📍 Anaheim Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Tests: KarXT, Placebo Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD NCT07115238Phase 31 site📍 Beijing Sinotau Pharmaceutical Group · Tests: XTR006
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy